- Home
- CSBR vs DLHC Comparison
CSBR vs DLHC Comparison
Compare CSBR & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- DLHC
- Stock Information
- Founded
- CSBR 1985
- DLHC 1969
- Country
- CSBR United States
- DLHC United States
- Employees
- CSBR N/A
- DLHC N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- DLHC Business Services
- Sector
- CSBR Health Care
- DLHC Consumer Discretionary
- Exchange
- CSBR Nasdaq
- DLHC Nasdaq
- Market Cap
- CSBR 90.2M
- DLHC 80.0M
- IPO Year
- CSBR 1986
- DLHC N/A
- Fundamental
- Price
- CSBR $6.48
- DLHC $5.50
- Analyst Decision
- CSBR Strong Buy
- DLHC
- Analyst Count
- CSBR 1
- DLHC 0
- Target Price
- CSBR $12.00
- DLHC N/A
- AVG Volume (30 Days)
- CSBR 15.1K
- DLHC 11.0K
- Earning Date
- CSBR 09-15-2025
- DLHC 12-03-2025
- Dividend Yield
- CSBR N/A
- DLHC N/A
- EPS Growth
- CSBR N/A
- DLHC 80.25
- EPS
- CSBR 0.21
- DLHC 0.31
- Revenue
- CSBR $56,878,000.00
- DLHC $359,723,000.00
- Revenue This Year
- CSBR $7.31
- DLHC N/A
- Revenue Next Year
- CSBR $12.01
- DLHC N/A
- P/E Ratio
- CSBR $30.18
- DLHC $17.81
- Revenue Growth
- CSBR 10.11
- DLHC N/A
- 52 Week Low
- CSBR $3.75
- DLHC $2.72
- 52 Week High
- CSBR $11.99
- DLHC $9.58
- Technical
- Relative Strength Index (RSI)
- CSBR 47.59
- DLHC 45.57
- Support Level
- CSBR $6.29
- DLHC $5.50
- Resistance Level
- CSBR $6.79
- DLHC $5.66
- Average True Range (ATR)
- CSBR 0.25
- DLHC 0.12
- MACD
- CSBR 0.03
- DLHC -0.01
- Stochastic Oscillator
- CSBR 33.83
- DLHC 0.00
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.